KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Operations (2017 - 2025)

Guardant Health's Cash from Operations history spans 9 years, with the latest figure at 26373000.0 for Q4 2025.

  • For Q4 2025, Cash from Operations rose 59.12% year-over-year to 26373000.0; the TTM value through Dec 2025 reached 184760000.0, up 22.97%, while the annual FY2025 figure was 184760000.0, 22.97% up from the prior year.
  • Cash from Operations for Q4 2025 was 26373000.0 at Guardant Health, up from 35413000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 16291000.0 in Q1 2021 and bottomed at 111935000.0 in Q2 2022.
  • The 5-year median for Cash from Operations is 63601000.0 (2024), against an average of 63403650.0.
  • The largest annual shift saw Cash from Operations tumbled 559.61% in 2021 before it surged 59.32% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 76988000.0 in 2021, then dropped by 17.87% to 90749000.0 in 2022, then increased by 13.25% to 78728000.0 in 2023, then increased by 18.06% to 64513000.0 in 2024, then surged by 59.12% to 26373000.0 in 2025.
  • Per Business Quant, the three most recent readings for GH's Cash from Operations are 26373000.0 (Q4 2025), 35413000.0 (Q3 2025), and 60285000.0 (Q2 2025).